JP2023551194A5 - - Google Patents

Info

Publication number
JP2023551194A5
JP2023551194A5 JP2023530548A JP2023530548A JP2023551194A5 JP 2023551194 A5 JP2023551194 A5 JP 2023551194A5 JP 2023530548 A JP2023530548 A JP 2023530548A JP 2023530548 A JP2023530548 A JP 2023530548A JP 2023551194 A5 JP2023551194 A5 JP 2023551194A5
Authority
JP
Japan
Application number
JP2023530548A
Other languages
Japanese (ja)
Other versions
JP2023551194A (ja
JPWO2022109313A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/060161 external-priority patent/WO2022109313A1/en
Publication of JP2023551194A publication Critical patent/JP2023551194A/ja
Publication of JP2023551194A5 publication Critical patent/JP2023551194A5/ja
Publication of JPWO2022109313A5 publication Critical patent/JPWO2022109313A5/ja
Pending legal-status Critical Current

Links

JP2023530548A 2020-11-20 2021-11-19 ウシ科動物抗体バリアント Pending JP2023551194A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063116491P 2020-11-20 2020-11-20
US63/116,491 2020-11-20
PCT/US2021/060161 WO2022109313A1 (en) 2020-11-20 2021-11-19 Bovine antibody variants

Publications (3)

Publication Number Publication Date
JP2023551194A JP2023551194A (ja) 2023-12-07
JP2023551194A5 true JP2023551194A5 (https=) 2024-11-07
JPWO2022109313A5 JPWO2022109313A5 (https=) 2024-11-07

Family

ID=79018979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023530548A Pending JP2023551194A (ja) 2020-11-20 2021-11-19 ウシ科動物抗体バリアント

Country Status (12)

Country Link
US (1) US20230416410A1 (https=)
EP (1) EP4247851A1 (https=)
JP (1) JP2023551194A (https=)
KR (1) KR20230110297A (https=)
CN (1) CN116615463A (https=)
AR (1) AR124130A1 (https=)
AU (1) AU2021382704A1 (https=)
BR (1) BR112023008490A2 (https=)
CA (1) CA3202089A1 (https=)
CO (1) CO2023007146A2 (https=)
MX (1) MX2023005896A (https=)
WO (1) WO2022109313A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023552456A (ja) 2020-12-07 2023-12-15 インベテックス インコーポレイテッド 治療薬の家畜動物における半減期を増加させるための組成物及びその使用方法
CN119730881A (zh) * 2022-08-05 2025-03-28 硕腾服务有限责任公司 牛抗体突变体
CN119968390A (zh) * 2022-09-02 2025-05-09 硕腾服务有限责任公司 猪抗体突变体
CN119735654B (zh) * 2025-02-27 2025-07-01 浙江海隆生物科技股份有限公司 一种牛副流感病毒的亚单位hn蛋白制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US5698762A (en) 1994-12-09 1997-12-16 Dauerman; Leonard Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons
US20030031671A1 (en) 2001-08-01 2003-02-13 Sydney Welt Methods of treating colon cancer utilizing tumor-specific antibodies
KR20070057839A (ko) 2004-08-19 2007-06-07 제넨테크, 인크. 변경된 이펙터 기능을 갖는 폴리펩티드 변이체
US8546543B2 (en) 2004-11-12 2013-10-01 Xencor, Inc. Fc variants that extend antibody half-life
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
DK1817340T3 (da) 2004-11-12 2012-08-13 Xencor Inc Fc-varianter med ændret binding til fcrn
TWI633117B (zh) * 2012-09-13 2018-08-21 必治妥美雅史谷比公司 結合至肌肉生長抑制素(myostatin)以纖維連接蛋白爲主之支架結構域蛋白質
EP3359190A4 (en) * 2015-10-05 2020-05-06 Circle33 LLC ANTIBODIES WITH IMPROVED STABILITY ABOUT DIGESTION

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)